Deep Brain Stimulation (DBS) in Pantothenate Kinase-Associated Neurodegeneration (PKAN): An Experience in a Thai Patient
Objective: To report a patient with PKAN whose dystonia improved with bilateral pallidal (GPi) DBS. Background: The benefits of GPi DBS are well-recognized in primary…Deep brain stimulation-guided optogenetic rescue of parkinsonian symptoms
Objective: Using opto-activation of cortical interneurons, we aimed at mimicking the cortical effects of deep brain stimulation of the subthalamic nucleus (STN-DBS) to reproduce its…Developing an innovative telephone support line for people with Parkinson’s Disease
Objective: To develop a novel care approach using a nurse led telephone helpline specialized and dedicated to persons with Parkinson’s Disease (PD). Background: PD is…Reconstructing the history of Machado-Joseph disease
Objective: The authors debate if previous descriptions of cerebellar ataxias with autossomal dominant pattern of inheritance, resembling MJD phenotipically, should gain the merit of first…Opsoclonus-Myoclonus-Ataxia Syndrome – Ljubljana University Children’s Hospital clinical series
Objective: Analysis of number, clinical characteristics and outcome of patients admitted to our department due to OMS in the past 25 years. Background: Opsoclonus-myoclonus-ataxia syndrome…The impact of non-motor symptoms on the quality of life of patients with Parkinson’s disease depending on its stages
Objective: To study impact of non-motor symptoms evaluated with the Non-Motor Symptoms Scale (NMSS) and on Parkinson’s disease (PD) patients’ quality of life (QOL) depending…(Not) sleeping with the enemy: Cognitive correlates of nocturnal sleep disturbances in Parkinson’s disease
Objective: To evaluate cognitive correlates of nocturnal sleep dysfunction in patients with idiopathic Parkinson’s disease (PD). Background: Sleep disturbances are among the most troublesome and…Cognitive Inhibitory Control and Response to Dopaminergic Medication in Parkinson’s Disease
Objective: To investigate whether response to dopaminergic medication (DM) correlates to inhibitory cognitive control (IC) in patients with Parkinson's disease (PD). Background: In the MDS…Comparison of Zonisamide with Non-Levodopa, Anti-Parkinson’s disease Drugs in the Incidence of Parkinson’s Disease-Relevant Symptoms
Objective: This study was to compare zonisamide and other anti-PD drugs by analyzing their associations with the incidence of PD-relevant symptoms. Background: Patients with Parkinson’s…Exploring the Lexicon of Fatigue in Parkinson Disease: A Qualitative Approach
Objective: To understand how patients with Parkinson disease (PD) experience fatigue and identify potential communication barriers between doctors and patients. Background: Fatigue in PD is…
- « Previous Page
- 1
- …
- 76
- 77
- 78
- 79
- 80
- …
- 217
- Next Page »